Summary:
As new drugs in development have poorer solubility and bioavailability, there is a need for novel solubility enhancing polymers to improve drug loading and improve patient adherence.
In this podcast, Nick DiFranco explains some of the shortcomings of traditional solubility enhancers as well as key considerations for novel technologies. Nick also presents an overview of Lubrizol’s Apinovex™ polymers for oral solubility enhancement and Apisolex™ polymers for injectable solubility enhancement.
For more information about Lubrizol Life Science, visit Lubrizol.com.
For more information about the PODD Conference, please visit PODDConference.com.
Speakers
Nick DiFranco, MEM
Global Market Manager, Oral Drug Delivery and Novel Excipients
Lubrizol Life Science
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.